000			01690 a2200517 4500
005			20250514025543.0
264		0	_c20020416
008			200204s 0 0 eng d
022			_a1474-175X
024	7		_a10.1038/nrc705 _2doi
040			_aNLM _beng _cNLM
100	1		_aSchoen, Robert E
245	0	0	_aThe case for population-based screening for colorectal cancer. _h[electronic resource]
260			_bNature reviews. Cancer _cJan 2002
300			_a65-70 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAdenoma _xdiagnosis
650	0	4	_aAdenomatous Polyps _xdiagnosis
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aBarium Compounds
650	0	4	_aBiomarkers, Tumor _xanalysis
650	0	4	_aColonic Polyps _xdiagnosis
650	0	4	_aColonography, Computed Tomographic _xeconomics
650	0	4	_aColonoscopy _xeconomics
650	0	4	_aColorectal Neoplasms _xepidemiology
650	0	4	_aCost-Benefit Analysis
650	0	4	_aDisease Progression
650	0	4	_aFeces _xchemistry
650	0	4	_aGenes, ras
650	0	4	_aHumans
650	0	4	_aIntestinal Polyps _xdiagnosis
650	0	4	_aMass Screening _xeconomics
650	0	4	_aMiddle Aged
650	0	4	_aOccult Blood
650	0	4	_aPatient Acceptance of Health Care
650	0	4	_aPatient Compliance
650	0	4	_aPredictive Value of Tests
650	0	4	_aProgram Evaluation
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aRisk
650	0	4	_aSensitivity and Specificity
650	0	4	_aSigmoidoscopy
773	0		_tNature reviews. Cancer _gvol. 2 _gno. 1 _gp. 65-70
856	4	0	_uhttps://doi.org/10.1038/nrc705 _zAvailable from publisher's website
999			_c11808497 _d11808497